Istanbul Gelisim University - IGU is the university patent champion

IGU is the university patent champion

Patent Effect announced Turkey's 2020 patent report. It has been reported that Istanbul Gelisim University (IGU) became the university patent champion with 92 patent applications. Having reached 571 applications, IGU increased its patent portfolio by 119 percent.

According to the report, the number of patents or utility models licensed by universities increased from 28 in 2019 to 49 in 2020. The number of commercialization of universities increased from 28 in 2019 to 46 in 2020. While the total number of commercialization was 121, the number of commercialized patents reached 117. In 2020, the number of universities that made at least one commercialization was 16. The number of universities that made at least one commercialization in total increased to 23.

"PATENT APPLICATIONS INCREASED DESPITE THE OUTBREAK"

Stating that patent applications for the Covid-19 epidemic have increased, Istanbul Gelisim University Chairman of the Board of Trustees Abdülkadir Gayretli said, “The announced reports show that patent applications have increased by 50 percent and utility model applications by 111 percent. It is stated that during the epidemic process, a large amount of patent and utility model applications were made, especially for health and epidemic-fighting products.

"WE WILL INCREASE THE GAINS FROM THE PATENTS"

Reminding that under the leadership of Prof. Dr. Yekta Saraç The Council of Higher Education (CoHE) carried out studies focusing on university-industry cooperation, Abdülkadir Gayretli said, “We were found successful by the Ministry of Industry KOSGEB by establishing the ‘Gelisim Biotech Tekmer’ incubation center. We offer a common working area to all entrepreneurs who produce projects in the fields of basic science and engineering, and contribute to science and economy in Turkey with the incubator center. We aim to bring together entrepreneurs and industry representatives with investors, lay the groundwork for qualified collaborations, and increase the profit we will gain from patents we license.”